journal article·2022-07-29Open access

Anti-Inflammatory and Mineralization Effects of an ASP/PLGA-ASP/ACP/PLLA-PLGA Composite Membrane as a Dental Pulp Capping Agent

Wenjuan Yan, Fenghe Yang, Zhongning Liu, Quan Wen, Yike Gao, Xufeng Niu, Yuming Zhao

Abstract

Dental pulp is essential for the development and long-term preservation of teeth. Dental trauma and caries often lead to pulp inflammation. Vital pulp therapy using dental pulp-capping materials is an approach to preserving the vitality of injured dental pulp. Most pulp-capping materials used in clinics have good biocompatibility to promote mineralization, but their anti-inflammatory effect is weak. Therefore, the failure rate will increase when dental pulp inflammation is severe. The present study developed an amorphous calcium phosphate/poly (L-lactic acid)-poly (lactic-co-glycolic acid) membrane compounded with aspirin (hereafter known as ASP/PLGA-ASP/ACP/PLLA-PLGA). The composite membrane, used as a pulp-capping material, effectively achieved the rapid release of high concentrations of the anti-inflammatory drug aspirin during the early stages as well as the long-term release of low concentrations of aspirin and calcium/phosphorus ions during the later stages, which could repair inflamed dental pulp and promote mineralization. Meanwhile, the composite membrane promoted the proliferation of inflamed dental pulp stem cells, downregulated the expression of inflammatory markers, upregulated the expression of mineralization-related markers, and induced the formation of stronger reparative dentin in the rat pulpitis model. These findings indicate that this material may be suitable for use as a pulp-capping material in clinical applications.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Mesenchymal stem cell research · Periodontal Regeneration and Treatments · Bone and Dental Protein Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pediatric Dentistry, Peking University School and Hospital of Stomatology & National Center of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterials and Digital Medical Devices & Beijing Key Laboratory of Digital Stomatology & Research Center of Engineering and Technology for Computerized Dentistry Ministry of Health & NMPK Key Laboratory for Dental Materials, Beijing 100081, China

Department of First Clinical Division, Peking University School and Hospital of Stomatology & National Center of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterials and Digital Medical Devices & Beijing Key Laboratory of Digital Stomatology & Research Center of Engineering and Technology for Computerized Dentistry Ministry of Health & NMPK Key Laboratory for Dental Materials, Beijing 100081, China

Key Laboratory of Biomechanics and Mechanobiology, Ministry of Education, Beijing Advanced Innovation Center for Biomedical Engineering, School of Biological Science and Medical Engineering, Beihang University, Beijing 100083, China

Department of Prosthodontics, Peking University School and Hospital of Stomatology & National Center of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterials and Digital Medical Devices & Beijing Key Laboratory of Digital Stomatology & Research Center of Engineering and Technology for Computerized Dentistry Ministry of Health& NMPK Key Laboratory for Dental Materials, Beijing 100081, China

Funding

Beijing Natural Science Foundation · National Natural Science Foundation of China · Beijing Nova Program of Science and Technology

References (79)

Show source-provided references
1. Dental pulp and dentin tissue engineering and regeneration: Advancement and challenge10.2741/e286 ↗
2. Vital pulp therapy in vital permanent teeth with cariously exposed pulp: A systematic review10.1016/j.joen.2010.12.004 ↗
3. Vital Pulp Therapy an Insight Over the Available Literature and Future Expectations
4. Kunert, M., and Lukomska-Szymanska, M. (2020). Bio-Inductive Materials in Direct and Indirect Pulp Capping-A Review Article. Materials, 13.10.3390/ma13051204 ↗
5. Bio-Inductive Materials in Direct and Indirect Pulp s of Human and Rat Dental Pulps In Vitro and In Vivo10.1016/j.joen.2018.07.012 ↗
6. Pulp Inflammation Diagnosis from Clinical to Inflammatory Mediators: A Systematic Review10.1016/j.joen.2017.02.009 ↗
7. Diagnosis of the condition of the dental pulp: A systematic review10.1111/j.1365-2591.2012.02016.x ↗
8. Mineral trioxide aggregate and other bioactive endodontic cements: An updated overview—Part I: Vital pulp therapy10.1111/iej.12841 ↗
9. Current trends and future perspectives of dental pulp capping materials: A systematic review10.1002/jbm.b.33934 ↗
10. Designing new treatment strategies in vital pulp therapy10.1016/S0300-5712(99)00047-0 ↗
11. Di Bella, S., Luzzati, R., and Principe, L. (2022). Aspirin and Infection: A Narrative Review. Biomedicines, 10.10.3390/biomedicines10020263 ↗
12. Acetylsalicylic Acid Treatment Improves Differentiation and Immunomodulation of SHED10.1177/0022034514557672 ↗
13. Utility of Amorphous Calcium Phosphate-Based Scaffolds in Dental/Biomedical Applications
14. Niu, X., Liu, Z., Tian, F., Chen, S., Lei, L., Jiang, T., Feng, Q., and Fan, Y. (2017). Sustained delivery of calcium and orthophosphate ions from amorphous calcium phosphate and poly(L-lactic acid)-based electrospinning nanofibrous scaffold. Sci. Rep., 7.10.1038/srep45655 ↗
15. Biodegradation and biocompatibility of PLA and PLGA microspheres10.1016/S0169-409X(97)00048-3 ↗
16. PLGA-based biodegradable microspheres in drug delivery: Recent advances in research and application10.1080/10717544.2021.1938756 ↗
17. Vlachopoulos, A., Karlioti, G., Balla, E., Daniilidis, V., Kalamas, T., Stefanidou, M., Bikiaris, N.D., Christodoulou, E., Koumentakou, I., and Karavas, E. (2022). Poly(Lactic Acid)-Based Microparticles for Drug Delivery Applications: An Overview of Recent Advances. Pharmaceutics, 14.10.3390/pharmaceutics14020359 ↗
18. Recent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics10.1016/j.msec.2017.12.036 ↗
19. Quantitative Microbiological Study of Human Carious Dentine by Culture and Real-Time PCR: Association of Anaerobes with Histopathological Changes in Chronic Pulpitis10.1128/JCM.40.5.1698-1704.2002 ↗
20. Role of SIRT1 in Heat Stress- and Lipopolysaccharide-induced Immune and Defense Gene Expression in Human Dental Pulp Cells10.1016/j.joen.2011.07.006 ↗
21. Hereditary dentine disorders: Dentinogenesis imperfecta and dentine dysplasia10.1186/1750-1172-3-31 ↗
22. Amelogenesis imperfecta10.1186/1750-1172-2-17 ↗
23. Telescopic overdenture on natural teeth: Prosthetic rehabilitation on (OFD) syndromic patient and a review on available literature
24. Pulp therapy for primary and immature permanent teeth: An overview
25. Conservative pulp therapy in the management of reversible and irreversible pulpitis10.1111/adj.12841 ↗
26. Long-term evaluation of direct pulp capping--treatment outcomes over an average period of 6.1 years10.1007/s00784-009-0326-9 ↗
27. Outcomes of nonsurgical retreatment and endodontic surgery: A systematic review10.1016/j.joen.2009.04.023 ↗
28. Root Canal Filled Versus Non-Root Canal Filled Teeth: A Retrospective Comparison of Survival Times10.1111/j.1752-7325.2005.tb02792.x ↗
29. Human postnatal dental pulp cells co-differentiate into osteoblasts and endotheliocytes: A pivotal synergy leading to adult bone tissue formation10.1038/sj.cdd.4402121 ↗
30. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo10.1073/pnas.240309797 ↗
31. Dental Pulp Tissue Regeneration Using Dental Pulp Stem Cells Isolated and Expanded in Human Serum10.1016/j.joen.2016.11.018 ↗
32. Farges, J.-C., Alliot-Licht, B., Renard, E., Ducret, M., Gaudin, A., Smith, A.J., and Cooper, P.R. (2015). Dental Pulp Defence and Repair Mechanisms in Dental Caries. Mediat. Inflamm., 2015.10.1155/2015/230251 ↗
33. Dose-specific effects of tumor necrosis factor alpha on osteogenic differentiation of mesenchymal stem cells10.1111/j.1365-2184.2011.00769.x ↗
34. Scaffolds to Control Inflammation and Facilitate Dental Pulp Regeneration10.1016/j.joen.2014.01.019 ↗
35. Epigenetic Approaches to the Treatment of Dental Pulp Inflammation and Repair: Opportunities and Obstacles10.3389/fgene.2018.00311 ↗
36. Adherence to the preventive strategies for nonsteroidal anti-inflammatory drug- or low-dose aspirin-induced gastrointestinal injuries10.1007/s00535-013-0771-8 ↗
37. Aspirin, Nonaspirin Nonsteroidal Anti-inflammatory Drug, and Acetaminophen Use and Risk of Invasive Epithelial Ovarian Cancer: A Pooled Analysis in the Ovarian Cancer Association Consortium10.1093/jnci/djt431 ↗
38. Chokshi, R., Bennett, O., Zhelay, T., and Kozak, J.A. (2021). NSAIDs Naproxen, Ibuprofen, Salicylate, and Aspirin Inhibit TRPM7 Channels by Cytosolic Acidification. Front. Physiol., 12.10.3389/fphys.2021.727549 ↗
39. Brox, R., and Hackstein, H. (2021). Physiologically relevant aspirin concentrations trigger immunostimulatory cytokine production by human leukocytes. PLoS ONE, 16.10.1371/journal.pone.0254606 ↗
40. Fattahi, R., Mohebichamkhorami, F., Khani, M.M., Soleimani, M., and Hosseinzadeh, S. (2022). Aspirin effect on bone remodeling and skeletal regeneration: Review article. Tissue Cell, 76.10.1016/j.tice.2022.101753 ↗
41. Effects of aspirin-loaded graphene oxide coating of a titanium surface on proliferation and osteogenic differentiation of MC3T3-E1 cells10.1038/s41598-018-33353-7 ↗
42. Is aspirin treatment an appropriate intervention to osteoporosis?10.2217/17460816.3.6.499 ↗
43. Effects of non-steroidal anti-inflammatory drugs on proliferation, differentiation and migration in equine mesenchymal stem cells10.1042/CBI20090211 ↗
44. Aspirin promotes osteogenic differentiation of human dental pulp stem cells
45. A connectivity mapping approach predicted acetylsalicylic acid (aspirin) to induce osteo/odontogenic differentiation of dental pulp cells10.1111/iej.13281 ↗
46. IL-1β-induced MCP-1 expression and secretion of human dental pulp cells is related to TAK1, MEK/ERK, and PI3K/Akt signaling pathways10.1016/j.archoralbio.2015.10.008 ↗
47. Anti-inflammatory and repaired effects of non-steroidal anti-inflammatory drugs on human dental pulp cells
48. Marconi, G.D., Fonticoli, L., Guarnieri, S., Cavalcanti, M.F.X.B., Franchi, S., Gatta, V., Trubiani, O., Pizzicannella, J., and Diomede, F. (2021). Ascorbic Acid: A New Player of Epigenetic Regulation in LPS-gingivalis Treated Human Periodontal Ligament Stem Cells. Oxid. Med. Cell. Longev., 2021.10.1155/2021/6679708 ↗
49. Biological properties of modified bioactive glass on dental pulp cells10.1016/j.jdent.2019.01.017 ↗
50. 4-Methylumbelliferone administration enhances radiosensitivity of human fibrosarcoma by intercellular communication10.1038/s41598-021-87850-3 ↗
51. Immune responses of human dental pulp stem cells in lipopolysaccharide-induced microenvironment10.1002/cbin.10938 ↗
52. The Effect of Extracellular Calcium Ion on Gene Expression of Bone-related Proteins in Human Pulp Cells10.1097/00004770-200302000-00004 ↗
53. Ion Release, Porosity, Solubility, and Bioactivity of MTA Plus Tricalcium Silicate10.1016/j.joen.2014.03.025 ↗
54. Hydrolytic conversion of amorphous calcium phosphate into apatite accompanied by sustained calcium and orthophosphate ions release10.1016/j.msec.2016.04.095 ↗
55. Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: A review10.1016/j.actbio.2011.11.017 ↗
56. Roles of calcium phosphate-mediated integrin expression and MAPK signaling pathways in the osteoblastic differentiation of mesenchymal stem cells10.1039/C6TB00349D ↗
57. The effect of three different pulp capping cements on mineralization of dental pulp stem cells10.4012/dmj.2018-349 ↗
58. Gröninger, O., Hess, S., and Mohn, D. (2020). Directing Stem Cell Commitment by Amorphous Calcium Phosphate Nanoparticles Incorporated in PLGA: Relevance of the Free Calcium Ion Concentration. Int. J. Mol. Sci., 21.10.3390/ijms21072627 ↗
59. Im, S.H., Im, D.H., Park, S.J., Chung, J.J., Jung, Y., and Kim, S.H. (2021). Stereocomplex Polylactide for Drug Delivery and Biomedical Applications: A Review. Molecules, 26.10.3390/molecules26102846 ↗
60. Nanofiber-based delivery of bioactive agents and stem cells to bone sites10.1016/j.addr.2012.04.008 ↗
61. Usefulness of controlled release of growth factors in investigating the early events of dentin-pulp regeneration10.1016/j.joen.2012.11.007 ↗
62. Capuana, E., Lopresti, F., Ceraulo, M., and La Carrubba, V. (2022). Poly-l-Lactic Acid (PLLA)-Based Biomaterials for Regenerative Medicine: A Review on Processing and Applications. Polymers, 14.10.3390/polym14061153 ↗
63. Physical and mechanical properties of PLA, and their functions in widespread applications—A comprehensive review10.1016/j.addr.2016.06.012 ↗
64. PLGA-based nanoparticles as cancer drug delivery systems10.7314/APJCP.2014.15.2.517 ↗
65. Biodegradable nanoparticles for drug and gene delivery to cells and tissue10.1016/S0169-409X(02)00228-4 ↗
66. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices10.1016/S0142-9612(00)00115-0 ↗
67. Parhizkar, A., and Asgary, S. (2021). Local Drug Delivery Systems for Vital Pulp Therapy: A New Hope. Int. J. Biomater., 2021.10.1155/2021/5584268 ↗
68. Present and future of tissue engineering scaffolds for dentin-pulp complex regeneration
69. Functionalizing PLGA and PLGA Derivatives for Drug Delivery and Tissue Regeneration Applications
70. Peripheral nerve regeneration within an asymmetrically porous PLGA/Pluronic F127 nerve guide conduit10.1016/j.biomaterials.2007.11.036 ↗
71. Control of degradation rate and hydrophilicity in electrospun non-woven poly (D, L-lactide) nanofiber scaffolds for biomedical applications10.1016/S0142-9612(03)00407-1 ↗
72. Plasma surface modification of poly(D,L-lactic acid) as a tool to enhance protein adsorption and the attachment of different cell types10.1002/jbm.b.31068 ↗
73. Cell-Cell Adhesion-Driven Contact Guidance and Its Effect on Human Mesenchymal Stem Cell Differentiation10.1021/acsami.9b20939 ↗
74. Characterization of cell signaling, morphology, and differentiation potential of human mesenchymal stem cells based on cell adhesion mechanism10.1002/jcp.29587 ↗
75. Rocha, C.V., Gonçalves, V., da Silva, M.C., Bañobre-López, M., and Gallo, J. (2022). PLGA-Based Composites for Various Biomedical Applications. Int. J. Mol. Sci., 23.10.3390/ijms23042034 ↗
76. Poly-L-lactic acid/hydroxyapatite hybrid membrane for bone tissue regeneration10.1002/jbm.a.31166 ↗
77. Resorbable polyesters in cartilage engineering: Affinity and biocompatibility of polymer fiber structures to chondrocytes10.1002/(SICI)1097-4636(199622)33:2<57::AID-JBM1>3.0.CO;2-K ↗
78. Effects of pH on mineralization ability of human dental pulp cells10.1016/j.joen.2005.10.041 ↗
79. Casein phosphopeptides in oral health—Chemistry and clinical applications10.2174/138161207780363086 ↗